Federal health officials have confirmed that Rosabella-brand moringa powder capsules have been linked to a multistate outbreak of extensively drug‑resistant Salmonella, with cases reported across seven states, including one in Washington. According to the Washington State Department of Health, the outbreak investigation involves the CDC, FDA, and state public health agencies and remains ongoing. Details from the state’s advisory can be found through the Department of Health’s notice at 2026 Extensively Drug‑Resistant Salmonella Multistate Outbreak. Officials report seven infections nationally, three hospitalizations, and no deaths to date.

In Washington, one resident from King County has been identified among the affected individuals. Federal investigators have traced the outbreak to certain lots of Rosabella-brand moringa powder capsules distributed by Ambrosia Brands LLC. The FDA’s current outbreak update, available at FDA’s February 2026 investigation notice, reports that all interviewed patients consumed Rosabella capsules prior to becoming ill. Illness onset dates range from early November 2025 to early January 2026.

CDC officials emphasized the seriousness of the strain, noting that it is resistant to commonly recommended antibiotics. Their media alert, posted February 13, 2026, and accessible at CDC’s investigation notice, confirms the ongoing nature of the investigation and warns that treatment for severe infections may require alternative antibiotics.

Ambrosia Brands has recalled affected lots of Rosabella capsules, which were primarily sold online through multiple retail platforms. Illinois health officials have reiterated the recall guidance, advising consumers to check lot codes and discard or return any affected product. Their advisory can be read at Illinois Department of Public Health recall notice.

No cases have been reported in southwest Washington at this time, but state officials encourage residents who have purchased Rosabella-brand moringa capsules to verify whether their product is part of the recall. Symptoms of Salmonella infection can include fever, diarrhea, dehydration, or vomiting, and health agencies advise seeking medical attention if severe or persistent symptoms develop.